Cheikh Diack

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability.

Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability.

Journal: Ophthalmology and therapy

Published: January 14, 2026

Modeling Disease Progression and Placebo Response in Huntington Disease: Insights From Enroll-HD and GENERATION HD1 Cohorts.

Modeling Disease Progression and Placebo Response in Huntington Disease: Insights From Enroll-HD and GENERATION HD1 Cohorts.

Journal: Neurology

Published: May 02, 2025

Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.

Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.

Journal: Translational vision science & technology

Published: November 13, 2024

Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease.

Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease.

Journal: Translational vision science & technology

Published: November 13, 2024

Modeling of Parkinson's Disease Progression and Implications for Detection of Disease Modification in Treatment Trials.

Modeling of Parkinson's Disease Progression and Implications for Detection of Disease Modification in Treatment Trials.

Journal: Journal of Parkinson's disease

Published: July 26, 2024

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME.

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME.

Journal: Translational vision science & technology

Published: October 06, 2023

A model-based approach for historical borrowing, with an application to neovascular age-related macular degeneration.

A model-based approach for historical borrowing, with an application to neovascular age-related macular degeneration.

Journal: Statistical methods in medical research

Published: April 21, 2023

A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration.

A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration.

Journal: Translational vision science & technology

Published: June 10, 2021

Population pharmacokinetic analysis of RO5459072, a low water-soluble drug exhibiting complex food-drug interactions.

Population pharmacokinetic analysis of RO5459072, a low water-soluble drug exhibiting complex food-drug interactions.

Journal: British journal of clinical pharmacology

Published: June 22, 2020

Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.

Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.

Journal: Molecular pharmaceutics

Published: December 27, 2019

PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration.

PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: March 13, 2019

Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.

Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.

Journal: British journal of clinical pharmacology

Published: November 07, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026